The company's shares tumbled 5.60 per cent to close at Rs 2,616.95 on BSE. During the day, it tanked 7.81 per cent to Rs 2,555.55.
At NSE, shares dropped 5.57 per cent to close at Rs 2,615.35.
On the volume front, 1.13 lakh shares of the company were traded on BSE and over 18 lakh shares on NSE.
"This is to inform you that the audit of our formulations manufacturing plant- 3 at Bachupally, Hyderabad by USFDA, has been completed. We have been issued a Form 483 with 11 observations," Dr Reddy's Labs said in a filing to BSE on Friday.
We will address them comprehensively within the stipulated timeline, the filing added.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)